Compare EPC & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EPC | DRTS |
|---|---|---|
| Founded | 1999 | 2015 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 1999 | 2021 |
| Metric | EPC | DRTS |
|---|---|---|
| Price | $28.17 | $13.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $31.50 | $17.80 |
| AVG Volume (30 Days) | 440.4K | ★ 476.5K |
| Earning Date | 11-12-2026 | 11-23-2026 |
| Dividend Yield | ★ 2.14% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,223,500,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.92 | $1,235.59 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.73 | $3.43 |
| 52 Week High | $30.36 | $15.79 |
| Indicator | EPC | DRTS |
|---|---|---|
| Relative Strength Index (RSI) | 51.34 | 52.44 |
| Support Level | $26.34 | $13.73 |
| Resistance Level | $28.50 | $13.95 |
| Average True Range (ATR) | 1.16 | 0.62 |
| MACD | -0.00 | 0.12 |
| Stochastic Oscillator | 41.12 | 77.13 |
Edgewell Personal Care Co is a personal-care company. The operating segments of the company include Wet Shave, Sun and Skin Care and Feminine Care. Wet Shave products include razor handles and refillable blades, disposable shave products, and shaving gels and creams. Sun and Skin Care consists of sun care products, men's and women's grooming products, Billie women's grooming products and personal wipe products. Feminine Care products include tampons, pads and liners. Some of the brands offered by the company include Edge, Skintimate, Personna, Schick, Carefree, Playtex, Banana Boat and Hawaiian Tropic. It derives a majority of its revenue from the United States.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.